Compare Diageo plc (DEO) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diageo plc vs Enveric Biosciences Inc — how do they compare? Diageo plc trades at $94.63 (market cap $53.05B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: Diageo plc is far larger — about 8556.5× Enveric Biosciences Inc's market cap, and Diageo plc pays a 3.5% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| DEO | ENVB | |
|---|---|---|
Market Cap | $53.05B | $6.20M |
Sector | Technology | Health |
52-Week High | $115.33 | $17.40 |
52-Week Low | $72.47 | $1.27 |
Enterprise Value | $72.54B | $1.30M |
Dividend Yield | 3.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
